In a short period of time, TransCelerate has achieved unprecedented progress, delivering tangible impact to benefit the broader biopharmaceutical industry. All this would not have been achievable without the active engagement and sponsorship from some of the most senior leaders in the industry.
In just a few years, our leaders have made significant strides toward our goal of making clinical development more efficient. TransCelerate leadership has an unwavering dedication to assessing, refining and creating processes to make the drug development environment efficient, safe and innovative.
Chief Executive Officer
Chief Executive Officer, TransCelerate BioPharma Inc.
Senior Vice President, Head of Global Clinical Trial Operations, Merck
Senior Vice President, Drug Development Operations, Allergan
Board of Directors Leadership
Senior Vice President, Global Development, Amgen
Executive Vice President and Chief Medical Officer, UCB
Board of Directors
Senior Vice President, Head of Global Clinical Development, EMD Serono, Inc.
President, Global Development, Astellas Pharma
Senior Vice President, Corporate Division Medicine and Chief Medical Officer, Boehringer Ingelheim GmbH
Executive Vice President and Chief R&D Officer, Allergan
President of Global R&D, Sanofi
Executive Vice President of Science and Technology, Eli Lilly & Co.
Senior Vice President, Global Head of Pharma Regulatory and Policy, Roche
President, Pharmaceuticals R&D, GlaxoSmithKline
Chief Scientific Officer, Worldwide Chairman of Pharmaceuticals, Johnson & Johnson
Senior Vice President, Global Development, Novo Nordisk A/S
Chief Medical Officer, AbbVie
Executive Vice President, Chief Development Officer, Pfizer Inc.
Senior Vice President, Global Clinical Development, Merck Research Laboratories
Executive Vice President, Global Medicines Development, and Chief Medical Officer, AstraZeneca Pharmaceuticals
Senior Executive Officer, Executive General Manager, Global Development, Shionogi & Co., Ltd.
Senior Vice President, Global Operations
Senior Vice President, Global Operations, TransCelerate BioPharma, Inc.